Abrocitinib

Abrocitinib, sold under the brand name Cibinqo, is a Janus kinase inhibitor medication used for the treatment of atopic dermatitis (eczema).[2] It was developed by Pfizer.[2] Contents 1 Medical uses 2 Side effects 3 Pharmacology 3.1 Mechanism of action 3.2 Pharmacokinetics 4 History 5 Society and culture 5.1 Legal status 6 References 7 External links Medical uses Abrocitinib is indicated for the treatment of moderate-to-severe atopic dermatitis in ... [wikipedia]